格隆汇2月4日｜东吴证券研报指出，技源集团HMB领跑全球，精准营养扬帆起航。公司未来将继续发 力精准营养，以期打通产业链上中游。公司营养原料产品主要有HMB、氨基葡萄糖和硫酸软骨素， 2024年收入占比分别29%/18%/9%；公司制剂客户包括澳佳宝、Pharmacare、HerbsofGold等。HMB如日 方升，应用空间广阔，公司牢据优势位置；保健品行业景气成长，公司守正出新，精准营养扬帆起航。 考虑到公司的精准营养模式于业内先发优势及技术壁垒明显，且远期空间广阔，认为当下估值具备性价 比，首次覆盖，给予"买入"评级。 ...

Group 1: Micro Fund Development - The return logic of micro funds is primarily based on the valuation repair of low-attention assets and capital games, with a systematic selection of underpriced micro stocks to capture valuation recovery as attention increases [10][10][10] - Micro funds can be categorized into three types based on strategy implementation: active gaming type, flexible allocation type, and stable participation type, each differing in exposure, return elasticity, and drawdown characteristics [10][10][10] - The micro fund style is expected to have a phase of recovery and structural allocation value, benefiting from a friendly policy and liquidity environment under the "14th Five-Year Plan" [10][10][10] Group 2: Fixed Income Opportunities - The report recommends focusing on bond issuers within key supported industries under the "14th Five-Year Plan," using a qualitative and quantitative assessment method to identify the top 25% of issuers based on bond performance and fundamentals [3][3][3] - The analysis highlights that the majority of recommended issuers have bond balances of 2 billion yuan or more, with ratings predominantly at AAA and AA+ levels, indicating strong credit quality [3][3][3] - The report emphasizes the importance of monitoring macroeconomic conditions and industry policies, as well as the potential tightening of credit environments [3][3][3] Group 3: Company-Specific Insights - Jingdong Group's revenue is projected to reach 350.8 billion yuan in Q4 2025, with a slight year-on-year increase, while the retail business is expected to face pressure due to reduced government subsidies [20][20][20] - The company "Mingming Hen Mang" is positioned as a leading player in the snack retail sector, with projected revenues of 645 billion yuan in 2025, reflecting a significant growth trajectory [19][19][19] - The report anticipates that the company "Jiyuan Group" will maintain a strong market position in the health supplement industry, with a projected revenue of 10 billion yuan in 2024, driven by its innovative product offerings [17][17][17]

| [Table_EPS] 盈利预测与估值 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万元） | 891.89 | 1,001.86 | 1,083.22 | 1,312.06 | 1,568.91 | | 同比（%） | (5.84) | 12.33 | 8.12 | 21.13 | 19.58 | | 归母净利润（百万元） | 160.02 | 174.44 | 170.81 | 234.59 | 290.98 | | 同比（%） | 12.63 | 9.02 | (2.08) | 37.33 | 24.04 | | EPS-最新摊薄（元/股） | 0.40 | 0.44 | 0.43 | 0.59 | 0.73 | | P/E（现价&最新摊薄） | 68.97 | 63.27 | 64.61 | 47.05 | 37.93 | 证券研究报告·公司深度研究·食品加工 技源集团（603262） HMB 领跑全球，精准营养扬帆起航 2026 年 02 月 03 日 买入（首次 ...

Core Insights - The company, 技源集团, is a leading global supplier of HMB (β-Hydroxy β-Methylbutyrate), a crucial nutrient for muscle health, with a market share of approximately 65.80% in 2022 [1] - HMB is recognized for its unique ability to both increase muscle protein synthesis and reduce muscle protein breakdown, making it suitable for various sectors including sports nutrition, elderly health, weight management, and post-operative recovery [1] - The global demand for HMB is projected to grow, with estimated production volumes of 1,662.43 tons in 2023 and 1,758.50 tons in 2024, indicating a market share of around 52.27% and 53.34% for the company respectively [1] Financial Performance - For the first half of 2025, the company reported a revenue of 560 million yuan, representing a year-on-year growth of 15.65% [2] - Revenue from nutritional raw materials reached 390 million yuan, up 18.94%, while formulation product sales amounted to 170 million yuan, growing by 8.75% [2] - HMB sales specifically generated 158 million yuan, reflecting a growth of 3.75% [2] Market Development - The company maintains stable partnerships with major clients like Abbott while actively exploring new market opportunities and customer bases [2] - New HMB products are being developed for various applications, including adult milk powder for healthy aging and differentiated products for sports nutrition [2] - The company is also pursuing opportunities in pet nutrition and animal feed, collaborating with a large international agricultural enterprise [2]

Group 1 - The number of listed companies disclosing data is steadily increasing, indicating the maturation of China's nutrition and health industry [1] - Jiyuan Group shows considerable growth potential for HMB [1] - Minsheng Health is promoting stable growth in its mineral business through the synergy of online and offline channels [1] Group 2 - The third-quarter reports of seven major listed chain pharmacies have been released, revealing that Dazhenlin, Yifeng Pharmacy, Shuyapingmin, and Huaren Health achieved both revenue and net profit growth, while Laobaixing, Yixintang, and Jianzhijia experienced declines in both metrics [1] - The overall expansion speed of chain pharmacies has noticeably slowed, with a shift in focus from scale expansion to quality improvement and efficiency [1] - Specific performance data for the seven listed chain pharmacies for the first three quarters of the year includes: - Dazhenlin: Revenue of 20.068 billion, up 1.71%; Net profit of 1.081 billion, up 25.97% - Yifeng Pharmacy: Revenue of 17.286 billion, up 0.39%; Net profit of 1.225 billion, up 10.27% - Laobaixing: Revenue of 16.07 billion, down 1%; Net profit of 529 million, down 16.11% - Yixintang: Revenue of 13.001 billion, down 4.33%; Net profit of 269 million, down 8.17% - Jianzhijia: Revenue of 6.549 billion, down 2.80%; Net profit of 101 million, down 0.20% - Shuyapingmin: Revenue of 7.446 billion, up 5.19%; Net profit of 1.09 billion, up 927.37% - Huaren Health: Revenue of 3.892 billion, up 19.06%; Net profit of 157 million, up 45.21% [1] Group 3 - The trademark dispute involving Tongrentang is expected to come to an end as the acquisition of Tianjin Tongrentang Group's shares by Beijing Tongrentang Group has entered the acceptance stage, allowing Beijing Tongrentang to hold 60% of Tianjin Tongrentang [2] Group 4 - Six stores of Laobaixing in Loudi, Hunan Province were penalized for insurance fraud, where they switched health products for insurance-covered medications, leading to a fine and the revocation of their insurance service agreements [3]

Group 1: Hengxin Life - Hengxin Life is a leading enterprise in the biodegradable food service ware industry, deeply bound to global top restaurant brands [1][10] - The company has established a production capacity of 9 billion paper and plastic food service items annually, with multiple production bases in China and a global layout including a factory in Thailand [1][10] - The demand for food service ware is robust, driven by urbanization and rising income levels, leading to an upgrade in consumer expectations for quality, environment, service, and experience [1][25] - The revenue from paper food service products is the highest, with a gross margin of 36.09%, while plastic food service products also maintain a high gross margin of 33.97% [11][12] - The company has shown significant revenue growth from 420 million in 2020 to 1.594 billion in 2024, with a compound annual growth rate (CAGR) of 39.21% [15][24] Group 2: Hanhai Group - Hanhai Group is a prominent brand in the domestic home hardware and outdoor furniture industry, with a strong reputation built over nearly 20 years [2][18] - The company has expanded its market share through product innovation and a comprehensive marketing network, with 381 distributors as of June 2025 [2][18] - The home hardware and outdoor furniture market is expected to grow significantly, driven by consumer upgrades and technological advancements [2][20] - Hanhai Group's revenue and net profit have shown rapid growth, with a notable increase in brand recognition among consumers [2][18] Group 3: Jiyuan Group - Jiyuan Group has over 20 years of experience in the dietary supplement industry, serving as a core supplier for many well-known brands [3][32] - The company is the largest global supplier of HMB, holding over 50% of the market share, and is also a key player in the glucosamine and chondroitin sulfate markets [3][32] - The dietary supplement market is expected to grow significantly due to increasing consumer awareness of health and nutrition [3][34] - Jiyuan Group has established a comprehensive supply chain and is actively developing innovative nutritional raw materials [3][42]

Core Insights - The company reported a revenue of 563 million yuan for the first half of 2025, representing a year-on-year increase of 15.65%, and a net profit attributable to shareholders of 98 million yuan, up 3.99% year-on-year [1] - In Q2 2025, the company achieved a revenue of 298 million yuan, a year-on-year increase of 14.83%, with a net profit attributable to shareholders of 55 million yuan, reflecting a slight increase of 0.26% year-on-year [1] Business Segments - **HMB**: In H1 2025, HMB sales reached 158 million yuan, a year-on-year increase of 3.75%. The company is expanding its market presence by launching differentiated adult milk powder products and new products targeting GLP-1 users [2] - **Glucosamine & Chondroitin Sulfate**: H1 2025 sales for glucosamine were 106 million yuan, up 9.82%, while chondroitin sulfate sales surged to 80 million yuan, a significant increase of 106.44%, primarily due to strong sales from major client Nutramax [2] - **Formulation Products**: H1 2025 tablet sales reached 119 million yuan, a year-on-year increase of 23.01%, driven by substantial sales growth in key markets [3] Financial Metrics - The company's gross margin and net profit margin for H1 2025 were 43.69% and 17.35%, respectively, showing a slight decline of 1.38 and 1.95 percentage points year-on-year, attributed to changes in product mix [4] - The company’s expense ratios for sales, management, finance, and R&D were 7.19%, 12.55%, -1.92%, and 4.33%, respectively, with notable increases in sales and management expense ratios [4] Strategic Initiatives - The company is focusing on enhancing its core competencies through the "One TSI" strategic organizational transformation and digitalization efforts, which are progressing as planned [5] - The company has developed an "Optimized Raw Material Technology Innovation Platform" to enhance product customization and differentiation, with new products targeting mid-to-high-end market segments [5] Profit Forecast - The company forecasts revenues of 1.184 billion yuan, 1.436 billion yuan, and 1.758 billion yuan for 2025-2027, with year-on-year growth rates of 18.2%, 21.2%, and 22.5%, respectively [5]

Group 1 - The global game console accessories market is projected to reach $16.49 billion in 2024 and $34.24 billion by 2031, with a compound annual growth rate (CAGR) of 11.2% from 2025 to 2031 [4] - The flexible tactile sensor market is expected to grow from approximately $1.53 billion in 2022 to $5.32 billion by 2029, with a CAGR of 17.9% [7][28] - The IoT smart terminal market for two-wheeled vehicles is forecasted to reach $19.75 billion by 2031, with a CAGR of 16.3% from 2025 to 2031 [11] Group 2 - The Southeast Asian metal packaging market for food and beverages is anticipated to reach $5.75 billion by 2029, providing significant growth opportunities for companies in the region [13] - The global electric scooter market is projected to reach $2.37 billion in 2024 and $5.685 billion by 2031, with a CAGR of 13.5% from 2025 to 2031 [16] - The automotive micro-motor market is expected to reach $20.4 billion by 2031, driven by the increasing use of micro-motors in high-end electric vehicles [18] Group 3 - The global SiC power module market is estimated to reach $65.71 billion by 2030, with a CAGR of 24.1% from 2024 to 2030 [20] - The edge AI chip market is projected to grow from $3.246 billion in 2024 to $9.342 billion by 2031, with a CAGR of 16.5% [22] - The quartz crystal component market is dominated by the top ten manufacturers, holding a combined market share of 66.4%, with the company ranking ninth globally at 3.08% [24] Group 4 - The global robotic multi-finger dexterous hand market is expected to exceed $5 billion by 2030, with a CAGR of 64.6% from 2024 to 2030 [51] - The global high-pressure cleaning machine market is projected to reach $4.42 billion by 2031, with a CAGR of 4.7% from 2025 to 2031 [53] - The global FMM market is expected to grow from $365 million in 2024 to $952 million by 2031, indicating a shift in industry dynamics [56]

Core Viewpoint - The company, Jiyuan Group, reported a revenue increase of 15.65% year-on-year for the first half of 2025, indicating strong growth in its business operations [1]. Financial Performance - The company's revenue for the first half of 2025 was 563 million yuan, with a net profit attributable to shareholders of 97.71 million yuan, reflecting a year-on-year growth of 3.99% [1]. - The basic earnings per share for the reporting period was 0.28 yuan, and the weighted average return on equity was 9.90% [2]. - The gross profit margin for the first half of 2025 was 43.69%, down 1.38 percentage points year-on-year, while the net profit margin was 17.44%, a decrease of 1.94 percentage points compared to the same period last year [3]. - In the second quarter of 2025, the gross profit margin was 43.82%, showing a year-on-year decline of 2.84 percentage points but a quarter-on-quarter increase of 0.29 percentage points [3]. - The net profit margin for the second quarter was 18.58%, down 2.70 percentage points year-on-year but up 2.43 percentage points from the previous quarter [3]. Expense Analysis - The company's total operating expenses for the first half of 2025 amounted to 125 million yuan, an increase of 20.68 million yuan compared to the same period last year, resulting in an expense ratio of 22.14%, up 0.78 percentage points year-on-year [3]. - Sales expenses increased by 37.30%, management expenses rose by 28.05%, and research and development expenses grew by 9.61%, while financial expenses decreased by 272.23% [3]. Shareholder Information - As of the end of the first half of 2025, the total number of shareholders was 13 [3]. Company Overview - Jiyuan Group, established on September 17, 2002, is located at 1089 North Qinzhou Road, Xuhui District, Shanghai. The company specializes in the research, innovation, and industrialization of dietary nutritional supplements [4]. - The main business revenue composition includes HMB (29.29%), tablets (22.53%), glucosamine (17.66%), chondroitin sulfate (9.06%), and other nutritional raw materials [4]. - The company is classified under the food and beverage industry, specifically in food processing and health products, and is part of several concept sectors including margin financing, newly listed stocks, and expected profit growth [4].

Group 1 - The core viewpoint of the news is that 技源集团 (Jiyuan Group) experienced a decline in stock price and had notable financing activities on August 27, 2023 [1] - On August 27, 2023, Jiyuan Group's stock price fell by 1.66%, with a trading volume of 145 million yuan [1] - The financing data indicates that Jiyuan Group had a financing buy-in amount of 11.97 million yuan and a financing repayment of 13.30 million yuan, resulting in a net financing buy of -1.33 million yuan [1] Group 2 - As of August 27, 2023, the total balance of margin trading for Jiyuan Group was 59.19 million yuan, accounting for 4.97% of its market capitalization [1] - The company has no outstanding short-selling activities, with zero shares sold or repaid on that date [1] - Jiyuan Group, established on September 17, 2002, focuses on the research, innovation, and industrialization of dietary nutritional supplements [1] Group 3 - As of July 23, 2023, Jiyuan Group had 62,200 shareholders, a significant increase of 478,138.46% compared to the previous period [2] - For the first quarter of 2025, Jiyuan Group reported a revenue of 265 million yuan, representing a year-on-year growth of 16.59%, and a net profit attributable to shareholders of 42.60 million yuan, up by 9.25% year-on-year [2]